BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38372252)

  • 1. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
    Shu L; Lin S; Zhou S; Yuan T
    Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface glycan-lectin interactions in tumor metastasis.
    Rambaruth ND; Dwek MV
    Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered tumor-cell glycosylation promotes metastasis.
    Häuselmann I; Borsig L
    Front Oncol; 2014; 4():28. PubMed ID: 24592356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelets and platelet receptors in cancer metastasis.
    Schlesinger M
    J Hematol Oncol; 2018 Oct; 11(1):125. PubMed ID: 30305116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
    Pearson AJ; Gallagher ES
    Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
    Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
    Front Oncol; 2016; 6():109. PubMed ID: 27242953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycan-Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them.
    Kremsreiter SM; Kroell AH; Weinberger K; Boehm H
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
    Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
    Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
    Shi Q; Ji T; Tang X; Guo W
    Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
    Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
    Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer.
    Kumar Das A; Ghosh N; Mandal A; Sil PC
    Biochem Pharmacol; 2023 Jan; 207():115367. PubMed ID: 36481348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional roles of protein glycosylation in human maternal-fetal crosstalk.
    Zhong J; Li J; Burton GJ; Koistinen H; Cheung KW; Ng EHY; Yao Y; Yeung WSB; Lee CL; Chiu PCN
    Hum Reprod Update; 2024 Jan; 30(1):81-108. PubMed ID: 37699855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances toward the development of inhibitors to attenuate tumor metastasis via the interruption of lectin-ligand interactions.
    Rachel H; Chang-Chun L
    Adv Carbohydr Chem Biochem; 2013; 69():125-207. PubMed ID: 24274369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.
    Stanley P; Sundaram S
    Curr Protoc Chem Biol; 2014 Jun; 6(2):117-133. PubMed ID: 24903886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
    Salatino M; Rabinovich GA
    Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycome profiling by lectin microarray reveals dynamic glycan alterations during epidermal stem cell aging.
    Oinam L; Changarathil G; Raja E; Ngo YX; Tateno H; Sada A; Yanagisawa H
    Aging Cell; 2020 Aug; 19(8):e13190. PubMed ID: 32681764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
    Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
    Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.